| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Replimune Group, Inc. | Director | Stock Option (right to buy) | 32,000 | 01 Apr 2025 | Direct | ||
| Coya Therapeutics, Inc. | Director | Stock Option (right to buy) | 10,000 | 02 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| COYA | Coya Therapeutics, Inc. | 02 Jan 2026 | 1 | $0 | 4 | Director | 06 Jan 2026, 19:26 |
| REPL | Replimune Group, Inc. | 01 Apr 2025 | 1 | $0 | 4 | Director | 03 Apr 2025, 20:01 |
| COYA | Coya Therapeutics, Inc. | 25 Feb 2025 | 1 | $0 | 4 | Director | 25 Feb 2025, 21:30 |
| COYA | Coya Therapeutics, Inc. | 01 Jan 2025 | 1 | $0 | 4 | Director | 03 Jan 2025, 21:30 |
| REPL | Replimune Group, Inc. | 01 Apr 2024 | 1 | $0 | 4 | Director | 03 Apr 2024, 20:00 |
| COYA | Coya Therapeutics, Inc. | 01 Jan 2024 | 1 | $0 | 4 | Director | 19 Jan 2024, 18:30 |
| COYA | Coya Therapeutics, Inc. | 18 Aug 2023 | 1 | $0 | 4 | Director | 21 Aug 2023, 21:15 |
| COYA | Coya Therapeutics, Inc. | 18 Aug 2023 | 0 | $0 | 3 | Director | 21 Aug 2023, 21:00 |
| REPL | Replimune Group, Inc. | 01 Apr 2023 | 1 | $0 | 4 | Director | 04 Apr 2023, 20:03 |
| REPL | Replimune Group, Inc. | 01 Apr 2022 | 1 | $0 | 4 | Director | 05 Apr 2022, 16:10 |